Immucor sells investment in instrument manufacturer:
This article was originally published in Clinica
Blood analysis equipment maker Immucor has sold its stake in Lionheart Technologies for about $1.3m. It was bought by Lionheart, the owner of Bio-Tek Instruments, one of Immucor's development and manufacturing partners. Winooski, Vermont-based Bio-Tek manufactures Immucor's ABS2000 automated blood bank laboratory analyser, and is developing a third-generation automated assay instrument for small to medium-sized hospitals. Bio-Tek's vice-president of business development, Adam Alpert, said the company "anticipate[d] no changes in this relationship as a consequence of the stock sale".
You may also be interested in...
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”
Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like Gilead’s remdesivir.
As American auto giants GM and Ford take the wheel on working with ventilator manufacturers to make the critically needed devices during the COVID-19 pandemic, two longtime quality experts explain where the device and auto companies will find common ground when it comes to quality systems.